ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Why Research Sites Don't Use EMR As The Source Data Collection Tool

  Examine the limitations of using Electronic Medical Records (EMRs) in clinical research compared to eSource systems.

• The Advantages Of DCTs In Diabetes Research

  By harnessing technology platforms, discover how researchers can be better equipped to design studies for novel diabetes treatments that are safer, more efficient, and more effective.

• A Better Approach To eConsent: Flexibility With Enabled Technology

  Electronic consent, or eConsent, digitalizes the trial participant consent process through increasingly simplified, interactive, educational models designed to improve comprehension and boost engagement.

• Do CROs Need To Reinvent Themselves In 2025?

  Facing economic pressures, regulatory changes, and technological advancements, CROs must redefine their value propositions and discuss the need for reinvention in 2025 to accelerate into the future.

• What Unified eCOA And IRT Can Unlock

  See how real-time scoring and automated eligibility checks helped a global dermatology study reduce site burden, avoid manual errors, and move participants through screening with greater speed.

• SMART On FHIR: Auto-Populate eCRFs On Study Day 1

  Get an overview of SMART on Fast Healthcare Interoperability (FHIR) for clinical trials, including workflow improvements, real-world data (RWD) integration, and reducing researcher burnout.

• Virtual eConsent For Decentralized Trials

  Virtual eConsent improves accessibility and compliance in decentralized trials, streamlining enrollment with a secure, user-friendly process for informed consent in remote research.

• Broadening Eligibility Criteria Among Cancer Clinical Trials Patients

  This study challenges the commonly applied exclusionary approach to clinical trials, particularly cancer trials, that underrepresent certain populations and limit the generalizability of research advancements.

• Paperless Online Remote Source Document Verification

  Learn how Clinical Trial Organizations, Monitoring Teams and Clinical Sites can benefit from the way Judi transforms rSDV from a logistical hurdle into a strategic asset.

• Shorten Trial Timelines With Better Evidence Generation

  Learn how digital data is helping the pharmaceutical industry tackle its most daunting challenge; the 12 year, $3 billion average to bring a new drug to market.